Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer

[Business Wire] – Bristol-Myers Squibb Company announced today the expiration, as of 11:59 p.m., New York City time, on May 26, 2015, of its previously announced cash tender offer for up to $500 . . . → Read More: Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer Similar Articles: Market Update (NYSE:BMY): Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C Regimen Stock Update (NYSE:BMY): Bristol-Myers Squibb to Present at Bank of America Merrill Lynch 2015 Health Care Conference Market Update (NYSE:BMY): Bristol-Myers Squibb Announces Cash Tender Offer For Up to $400 Million Aggregate Principal Amount of its Outstanding Debt Securities